NCT02689752View on ClinicalTrials.gov

A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] Fruquintinib

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Healthy
Interventions
DRUG

fruquintinib

fruquintinib suspension, 5mg ( 100mCi), oral, taken once, fast

Trial Locations (1)

210029

Jiangsu Province Hospital, Nanjing

All Listed Sponsors
lead

Hutchison Medipharma Limited

INDUSTRY

NCT02689752 - A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] Fruquintinib | Biotech Hunter | Biotech Hunter